Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionactin binding

PHACTR2 MYL3 SYNE1 SPTB DST SYNE2 PHACTR4 MYO1F AFDN PPP1R9B DIXDC1 TNS4 FMNL1

5.97e-0547914813GO:0003779
GeneOntologyMolecularFunctioncytoskeletal protein binding

PHACTR2 MYL3 SYNE1 SPTB KIF1B OBSCN RMDN3 DES DST SYNE2 PHACTR4 MYO1F AFDN PPP1R9B DIXDC1 TNS4 KIF13A FMNL1 MTUS2 NLRP5

1.81e-04109914820GO:0008092
GeneOntologyMolecularFunctioncadherin binding

CAST OBSCN CDH23 PPL TBC1D10A USO1 AFDN CDH6 SNX1 MPP7

2.24e-0433914810GO:0045296
GeneOntologyMolecularFunctionleptin receptor binding

SNX4 SNX1

3.24e-0441482GO:1990460
GeneOntologyMolecularFunctionprotein phosphatase inhibitor activity

PHACTR2 SH3RF2 PHACTR4 PPP1R9B

5.12e-04501484GO:0004864
GeneOntologyMolecularFunctioncell adhesion molecule binding

CAST OBSCN CDH23 VSIG10 PPL POSTN DST TBC1D10A USO1 AFDN CDH6 SNX1 MPP7

5.28e-0459914813GO:0050839
GeneOntologyMolecularFunctioncytoskeleton-nuclear membrane anchor activity

SYNE1 SYNE2

5.38e-0451482GO:0140444
GeneOntologyMolecularFunctionphosphatase inhibitor activity

PHACTR2 SH3RF2 PHACTR4 PPP1R9B

6.87e-04541484GO:0019212
GeneOntologyMolecularFunctionenzyme regulator activity

ERBB3 GRIPAP1 RAP1A PHACTR2 TBC1D2B CAST OBSCN ARHGAP30 APOA4 RGS9 ANKLE2 TBC1D10A PIK3CA SH3RF2 RALBP1 MOB1B PHACTR4 MOB1A PPP1R9B C3 ARHGEF37 HERC1

7.68e-04141814822GO:0030234
GeneOntologyMolecularFunctionprotein phosphatase regulator activity

PHACTR2 ANKLE2 SH3RF2 PHACTR4 PPP1R9B

8.94e-041001485GO:0019888
GeneOntologyCellularComponentcell-cell contact zone

OBSCN DES DST PIK3CA AFDN RAP2C ATP2A2

4.95e-06941497GO:0044291
GeneOntologyCellularComponentanchoring junction

RAP1A RAP1B OBSCN VSIG10 YES1 PPL DES FRMD4A SLC8A3 NPHS2 DST PIK3CA SYNE2 AFDN PPP1R9B DIXDC1 TNS4 RAP2C ATP2A2 CDH6 MPP7

6.02e-0697614921GO:0070161
GeneOntologyCellularComponentcell-cell junction

RAP1B OBSCN VSIG10 PPL DES FRMD4A NPHS2 DST PIK3CA AFDN PPP1R9B RAP2C ATP2A2 CDH6 MPP7

2.20e-0559114915GO:0005911
GeneOntologyCellularComponentextrinsic component of postsynaptic endosome membrane

GRIPAP1 SNX1

5.05e-0521492GO:0098999
GeneOntologyCellularComponentintercalated disc

OBSCN DES DST PIK3CA ATP2A2

1.25e-04681495GO:0014704
GeneOntologyCellularComponentextrinsic component of endosome membrane

GRIPAP1 SNX1

3.00e-0441492GO:0031313
GeneOntologyCellularComponenttype III intermediate filament

DES DST

7.43e-0461492GO:0045098
DomainSpectrin_repeat

DRP2 SYNE1 SPTB PPL DST SYNE2

8.78e-08291476IPR002017
DomainSPEC

DRP2 SYNE1 SPTB PPL DST SYNE2

1.64e-07321476SM00150
DomainSpectrin/alpha-actinin

DRP2 SYNE1 SPTB PPL DST SYNE2

1.64e-07321476IPR018159
DomainSpectrin

DRP2 SYNE1 SPTB DST SYNE2

8.47e-07231475PF00435
DomainGOLGA6L

GOLGA6L4 GOLGA6L10 GOLGA6L19

9.39e-0661473IPR026737
DomainACTININ_2

SYNE1 SPTB DST SYNE2

2.90e-05231474PS00020
DomainACTININ_1

SYNE1 SPTB DST SYNE2

2.90e-05231474PS00019
DomainActinin_actin-bd_CS

SYNE1 SPTB DST SYNE2

2.90e-05231474IPR001589
DomainCH

SYNE1 SPTB DST SYNE2 DIXDC1

1.59e-04651475SM00033
DomainCH

SYNE1 SPTB DST SYNE2 DIXDC1

2.26e-04701475PF00307
Domain-

SYNE1 SPTB DST SYNE2 DIXDC1

2.42e-047114751.10.418.10
DomainCH

SYNE1 SPTB DST SYNE2 DIXDC1

2.76e-04731475PS50021
DomainCH-domain

SYNE1 SPTB DST SYNE2 DIXDC1

3.13e-04751475IPR001715
DomainSH3

OBSCN YES1 SH3D21 DST SH3RF2 MYO1F ARHGEF37 MPP7

3.17e-042161478PS50002
DomainGOLGA2L5

GOLGA6L4 GOLGA6L10 GOLGA6L19

3.57e-04181473PF15070
DomainGolgin_A

GOLGA6L4 GOLGA6L10 GOLGA6L19

3.57e-04181473IPR024858
DomainSH3_domain

OBSCN YES1 SH3D21 DST SH3RF2 MYO1F ARHGEF37 MPP7

3.58e-042201478IPR001452
DomainKinesin-like_KIF1-typ

KIF1B KIF13A

3.65e-0441472IPR022140
DomainKASH

SYNE1 SYNE2

3.65e-0441472IPR012315
DomainKIF1B

KIF1B KIF13A

3.65e-0441472PF12423
DomainKASH

SYNE1 SYNE2

3.65e-0441472PS51049
DomainKASH

SYNE1 SYNE2

3.65e-0441472SM01249
DomainKASH

SYNE1 SYNE2

3.65e-0441472PF10541
DomainKinesin_assoc

KIF1B KIF13A

9.04e-0461472PF16183
DomainSPOC_C

PHF3 SPEN

9.04e-0461472IPR012921
DomainKinesin-like

KIF1B KIF13A

9.04e-0461472IPR022164
DomainKinesin_assoc

KIF1B KIF13A

9.04e-0461472IPR032405
DomainDUF3694

KIF1B KIF13A

9.04e-0461472PF12473
DomainSPOC

PHF3 SPEN

9.04e-0461472PF07744
DomainPROTEIN_KINASE_TYR

ERBB3 INSRR OBSCN YES1 EPHA7

1.02e-03971475PS00109
DomainTyr_kinase_AS

ERBB3 INSRR OBSCN YES1 EPHA7

1.02e-03971475IPR008266
DomainRPEL

PHACTR2 PHACTR4

1.26e-0371472PS51073
DomainRPEL

PHACTR2 PHACTR4

1.26e-0371472SM00707
DomainPlectin

PPL DST

1.26e-0371472PF00681
DomainRecep_L_domain

ERBB3 INSRR

1.26e-0371472PF01030
DomainMob1_phocein

MOB1B MOB1A

1.26e-0371472PF03637
DomainPlectin_repeat

PPL DST

1.26e-0371472IPR001101
DomainFurin-like

ERBB3 INSRR

1.26e-0371472PF00757
DomainRcpt_L-dom

ERBB3 INSRR

1.26e-0371472IPR000494
DomainRPEL

PHACTR2 PHACTR4

1.26e-0371472PF02755
DomainRAWUL

PCGF1 PCGF5

1.26e-0371472IPR032443
DomainFurin-like_Cys-rich_dom

ERBB3 INSRR

1.26e-0371472IPR006211
DomainRPEL_repeat

PHACTR2 PHACTR4

1.26e-0371472IPR004018
Domain-

ERBB3 INSRR

1.26e-03714723.80.20.20
DomainMOB_kinase_act_fam

MOB1B MOB1A

1.26e-0371472IPR005301
Domain-

MOB1B MOB1A

1.26e-03714721.20.140.30
DomainMob1_phocein

MOB1B MOB1A

1.26e-0371472SM01388
DomainRAWUL

PCGF1 PCGF5

1.26e-0371472PF16207
DomainPLEC

PPL DST

1.26e-0371472SM00250
DomainFHA

KIF1B AFDN KIF13A

1.35e-03281473SM00240
DomainSH3

OBSCN YES1 SH3D21 SH3RF2 MYO1F ARHGEF37 MPP7

1.63e-032161477SM00326
DomainCalx_beta

FREM3 SLC8A3

1.67e-0381472SM00237
DomainFHA_DOMAIN

KIF1B AFDN KIF13A

1.83e-03311473PS50006
DomainFHA

KIF1B AFDN KIF13A

1.83e-03311473PF00498
DomainCalx_beta

FREM3 SLC8A3

2.14e-0391472IPR003644
DomainCalx-beta

FREM3 SLC8A3

2.14e-0391472PF03160
DomainCadherin

CDH23 FREM3 CELSR1 PCDH19 CDH6

2.42e-031181475IPR002126
DomainZnf_C3HC4_RING-type

PCGF1 RNF114 PCGF5 TRIM10 SH3RF2 RLIM

2.43e-031721476IPR018957
DomainRAS

RAP1A RAP1B RAP2C

2.60e-03351473PS51421
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

CEP104 USP34 KIF1B SARM1 ADAMTSL3 PPL GREB1 ECE2

2.39e-0810515489628581
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

CEP104 USP34 SMG1 ERBB3 INSRR ZC3H4 FAM186A RLIM DIXDC1 HERC1 CTSD SPEN EPHA7

5.42e-084201541328065597
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

CYLC2 CEP104 SMG1 RAP1A RAP1B PHACTR2 NHSL2 SYNE1 ANKLE2 SH3D21 PPL DES DST FAM186A SYNE2 SEC23IP SMARCD2 PPP1R9B IFT122 UQCRB SPEN ATP2A2 CFAP46

1.05e-0714421542335575683
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CEP104 USP34 SMG1 SATB2 TBC1D2B ANKLE2 KMT2C DST ATP11B WASHC5 ZC3H4 DIXDC1 LZTS2 FTO

1.13e-075291541414621295
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

RAP1A REXO4 SYNE1 CHD1 YES1 C2CD2L RIOX2 RMDN3 SCAF1 KMT2C CELSR1 DST TBC1D10A TCERG1 PHF3 SGPL1 ASCC2 AFDN LZTS2 RAP2C SPEN ATP2A2 MPP7

2.03e-0714971542331527615
Pubmed

Proximity labelling identifies pro-migratory endocytic recycling cargo and machinery of the Rab4 and Rab11 families.

GRIPAP1 SNX4 RAP1B SYNE1 TBC1D2B YES1 USO1 PHACTR4 SEC23IP FMNL1 SNX1

3.73e-073391541137232246
Pubmed

Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.

USP34 SMG1 SYNE1 C2CD2L KMT2C DST ZC3H4 PHF3 SYNE2

7.95e-07225154912168954
Pubmed

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.

SMG1 CENPB NHSL2 SYNE1 CYP20A1 ATP11B UBE2V2 SGPL1 PHACTR4 SEC23IP SMARCD2 AFDN HERC1 KIF13A EPHA7

8.06e-077191541535337019
Pubmed

Rap1 regulates lumen continuity via Afadin in renal epithelia.

RAP1A RAP1B AFDN

2.94e-067154337276970
Pubmed

Loss of connectin novex-3 leads to heart dysfunction associated with impaired cardiomyocyte proliferation and abnormal nuclear mechanics.

SYNE1 OBSCN DES ATP2A2

4.35e-0625154438877142
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

USP34 ERBB3 SYNE1 SPTB KIF1B NSUN2 THOP1 DST TCERG1 CLK1 RALBP1 SEC23IP AFDN IFT122 HARS1 ATP2A2 MTUS2 SNX1 ECE2

4.46e-0612851541935914814
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

ERBB3 PHACTR2 CAST PPL DST TBC1D10A USO1 PHACTR4 AFDN LZTS2 SNX1 MPP7

8.91e-065651541225468996
Pubmed

Functional proteomics mapping of a human signaling pathway.

SMG1 ANKLE2 YES1 PPL DST ASCC2 AFDN PPP1R9B LZTS2 HERC1 KIF13A FMNL1

1.39e-055911541215231748
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

SMG1 COL12A1 SYNE1 SPTB KIF1B OBSCN DES DST CLK1 RALBP1 SYNE2

1.46e-054971541123414517
Pubmed

Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form.

RAP1A RAP1B

1.95e-052154213679863
Pubmed

Rap1 promotes endothelial mechanosensing complex formation, NO release and normal endothelial function.

RAP1A RAP1B

1.95e-052154225807985
Pubmed

Crosstalk between coagulation and complement activation promotes cardiac dysfunction in arrhythmogenic right ventricular cardiomyopathy.

DES C3

1.95e-052154233897891
Pubmed

Type XII collagen contributes to diversities in human corneal and limbal extracellular matrices.

COL12A1 C3

1.95e-05215429344363
Pubmed

Disruption of both nesprin 1 and desmin results in nuclear anchorage defects and fibrosis in skeletal muscle.

SYNE1 DES

1.95e-052154224943590
Pubmed

Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors.

ERBB3 PIK3CA

1.95e-052154228031425
Pubmed

Human endothelin converting enzyme-2 (ECE2): characterization of mRNA species and chromosomal localization.

EEF1AKMT4-ECE2 ECE2

1.95e-052154211718899
Pubmed

Satb2 Regulates EphA7 to Control Soma Spacing and Self-Avoidance of Cortical Pyramidal Neurons.

SATB2 EPHA7

1.95e-052154234546353
Pubmed

Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues.

SYNE1 SYNE2

1.95e-052154211792814
Pubmed

The Glutamine-Alanine Repeat Domain of TCERG1 is Required for the Inhibition of the Growth Arrest Activity of C/EBPα.

CEBPA TCERG1

1.95e-052154226264132
Pubmed

Rap1 Is Essential for B-Cell Locomotion, Germinal Center Formation and Normal B-1a Cell Population.

RAP1A RAP1B

1.95e-052154234140948
Pubmed

TCERG1 inhibits C/EBPα through a mechanism that does not involve sequestration of C/EBPα at pericentromeric heterochromatin.

CEBPA TCERG1

1.95e-052154221503969
Pubmed

Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration.

SYNE1 SYNE2

1.95e-052154224931616
Pubmed

Rap1B promotes VEGF-induced endothelial permeability and is required for dynamic regulation of the endothelial barrier.

RAP1A RAP1B

1.95e-052154229222111
Pubmed

Enhanced cortico-amygdala efficacy and suppressed fear in absence of Rap1.

RAP1A RAP1B

1.95e-052154218305243
Pubmed

Mutation in RAP1 is a rare event in myelodysplastic syndromes.

RAP1A RAP1B

1.95e-052154216118622
Pubmed

Mutation analysis of RAP1 gene in papillary thyroid carcinomas.

RAP1A RAP1B

1.95e-052154218948674
Pubmed

Expression of Rap 1 suppresses genomic instability of H-ras transformed mouse fibroblasts.

RAP1A RAP1B

1.95e-05215429330640
Pubmed

Rap1 GTPase activation and barrier enhancement in rpe inhibits choroidal neovascularization in vivo.

RAP1A RAP1B

1.95e-052154224039860
Pubmed

Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition.

RAP1A RAP1B

1.95e-052154231403469
Pubmed

CCAAT/enhancer-binding protein α is a crucial regulator of human fat mass and obesity associated gene transcription and expression.

CEBPA FTO

1.95e-052154224877091
Pubmed

Role of the small GTPase Rap1 for integrin activity regulation in endothelial cells and angiogenesis.

RAP1A RAP1B

1.95e-052154218805968
Pubmed

The rap GTPases regulate B cell morphology, immune-synapse formation, and signaling by particulate B cell receptor ligands.

RAP1A RAP1B

1.95e-052154218191594
Pubmed

Chromosome mapping of the human RAS-related RAP1A, RAP1B, and RAP2 genes to chromosomes 1p12----p13, 12q14, and 13q34, respectively.

RAP1A RAP1B

1.95e-05215422108841
Pubmed

Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins.

RAP1A RAP1B

1.95e-052154218056377
Pubmed

Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions.

RAP1A RAP1B

1.95e-052154218625726
Pubmed

Multiple novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular scaffolds.

SYNE1 SYNE2

1.95e-052154222768332
Pubmed

Identification of a co-repressor that inhibits the transcriptional and growth-arrest activities of CCAAT/enhancer-binding protein alpha.

CEBPA TCERG1

1.95e-052154216644732
Pubmed

Depletion of MOB1A/B causes intestinal epithelial degeneration by suppressing Wnt activity and activating BMP/TGF-β signaling.

MOB1B MOB1A

1.95e-052154230349003
Pubmed

Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.

MOB1B MOB1A

1.95e-052154223143302
Pubmed

Promotion of periostin expression contributes to the migration of Schwann cells.

ERBB3 POSTN

1.95e-052154226187852
Pubmed

Purification and characterization of the 22,000-dalton GTP-binding protein substrate for ADP-ribosylation by botulinum toxin, G22K.

RAP1A RAP1B

1.95e-05215423141412
Pubmed

Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation.

SYNE1 SYNE2

1.95e-052154217267447
Pubmed

Nesprins: tissue-specific expression of epsilon and other short isoforms.

SYNE1 SYNE2

1.95e-052154224718612
Pubmed

Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response.

SYNE1 SYNE2

1.95e-052154224586179
Pubmed

A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations.

ERBB3 PIK3CA

1.95e-052154225367220
Pubmed

Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.

SYNE1 SYNE2

1.95e-052154217761684
Pubmed

Nesprin-1-alpha2 associates with kinesin at myotube outer nuclear membranes, but is restricted to neuromuscular junction nuclei in adult muscle.

SYNE1 SYNE2

1.95e-052154231578382
Pubmed

The Rap1 small GTPase is a critical mediator of the effects of stress on prefrontal cortical dysfunction.

RAP1A RAP1B

1.95e-052154232651478
Pubmed

Human Mob1 proteins are required for cytokinesis by controlling microtubule stability.

MOB1B MOB1A

1.95e-052154222454515
Pubmed

Phosphoproteomics of the Dopamine Pathway Enables Discovery of Rap1 Activation as a Reward Signal In Vivo.

RAP1A RAP1B

1.95e-052154226804993
Pubmed

Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability.

RAP1A RAP1B

1.95e-052154232184389
Pubmed

Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.

ERBB3 PIK3CA

1.95e-052154223633485
Pubmed

Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis.

ERBB3 PIK3CA

1.95e-052154221725367
Pubmed

Telomere-dependent and telomere-independent roles of RAP1 in regulating human stem cell homeostasis.

RAP1A RAP1B

1.95e-052154230796637
Pubmed

Protein kinase A-dependent phosphorylation of Rap1 regulates its membrane localization and cell migration.

RAP1A RAP1B

1.95e-052154223946483
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

PHACTR2 ANKLE2 YES1 DST PIK3CA PCDH19 PHACTR4 SEC23IP SNX1 MPP7

1.98e-054211541036976175
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

KIF1B DST SGPL1 MOB1B MOB1A AFDN PPP1R9B LZTS2 FMNL1 MPP7

3.23e-054461541024255178
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

RAP1A TUT4 SPTB KIF1B CAST OBSCN ARMC2 CERT1 DNAH14 GMPS KMT2C THOP1 ATP11B PPP1R9B IFT122 GREB1 LZTS2 ARHGEF37 SLC4A5

3.46e-0514891541928611215
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

SMG1 ERBB3 POLE NSUN2 DST TCERG1 WASHC5 ZC3H4 SGPL1 AFDN IFT122 KYNU

3.53e-056501541238777146
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

USP34 REXO4 POLE CHD1 NSUN2 GMPS DST PHF3 SYNE2 AFDN SPEN ATP2A2

3.69e-056531541222586326
Pubmed

Rap2A links intestinal cell polarity to brush border formation.

RAP1A RAP1B RAP2C

3.73e-0515154322797597
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

USP34 GRIPAP1 REXO4 KIF1B PPL DST USO1 ZC3H4 PHACTR4 SEC23IP AFDN SPEN SNX1

4.56e-057771541335844135
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

RAP1A CAST ANKLE2 C2CD2L RMDN3 DST SYNE2 PHACTR4 SEC23IP FMNL1 SNX1

4.92e-055681541137774976
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

USP34 SMG1 CHD1 YES1 PCGF5 DST ZC3H4 CLK1 RALBP1 MOB1B NRK MOB1A LZTS2 EPHA7

5.70e-059101541436736316
Pubmed

Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.

RAP1A RAP1B

5.83e-053154224642466
Pubmed

Rap1 signaling prevents L-type calcium channel-dependent neurotransmitter release.

RAP1A RAP1B

5.83e-053154223616533
Pubmed

Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis.

PCGF1 CEBPA

5.83e-053154237266576
Pubmed

EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1.

MOB1B MOB1A

5.83e-053154234725466
Pubmed

Rap1 small GTPase is essential for maintaining pulmonary endothelial barrier function in mice.

RAP1A RAP1B

5.83e-053154238010922
Pubmed

Antibody targeting of HER2/HER3 signaling overcomes heregulin-induced resistance to PI3K inhibition in prostate cancer.

ERBB3 PIK3CA

5.83e-053154225471734
Pubmed

Large Extracellular Vesicle-Associated Rap1 Accumulates in Atherosclerotic Plaques, Correlates With Vascular Risks and Is Involved in Atherosclerosis.

RAP1A RAP1B

5.83e-053154232539601
Pubmed

The human tumour suppressor LATS1 is activated by human MOB1 at the membrane.

MOB1B MOB1A

5.83e-053154216674920
Pubmed

Rap1 and its effector RIAM are required for lymphocyte trafficking.

RAP1A RAP1B

5.83e-053154226324702
Pubmed

The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope.

SYNE1 SYNE2

5.83e-053154216079285
Pubmed

Structural basis for small G protein effector interaction of Ras-related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1).

RAP1A RAP1B

5.83e-053154222577140
Pubmed

SNX-BAR-mediated endosome tubulation is co-ordinated with endosome maturation.

SNX4 SNX1

5.83e-053154221973056
Pubmed

Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors.

CEBPA PPL

5.83e-053154210725330
Pubmed

Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B.

RAP1A RAP1B

5.83e-053154227760305
Pubmed

Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation.

F8 C3

5.83e-053154232582142
Pubmed

Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes.

RAP1A RAP1B

5.83e-053154220733035
Pubmed

CHD1 assumes a central role during follicle development.

CEBPA CHD1

5.83e-053154218817785
Pubmed

Localization of nectin-free afadin at the leading edge and its involvement in directional cell movement induced by platelet-derived growth factor.

RAP1A AFDN

5.83e-053154219887591
Pubmed

Small GTPase Rap1 Is Essential for Mouse Development and Formation of Functional Vasculature.

RAP1A RAP1B

5.83e-053154226714318
Pubmed

Syne-1, a dystrophin- and Klarsicht-related protein associated with synaptic nuclei at the neuromuscular junction.

SYNE1 SYNE2

5.83e-053154210878022
Pubmed

Sequential activation of Rap1 and Rac1 small G proteins by PDGF locally at leading edges of NIH3T3 cells.

RAP1A RAP1B

5.83e-053154218422604
Pubmed

The nesprins are giant actin-binding proteins, orthologous to Drosophila melanogaster muscle protein MSP-300.

SYNE1 SYNE2

5.83e-053154212408964
Pubmed

Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941.

ERBB3 PIK3CA

5.83e-053154219411071
Pubmed

Distinct functional domains in nesprin-1alpha and nesprin-2beta bind directly to emerin and both interactions are disrupted in X-linked Emery-Dreifuss muscular dystrophy.

SYNE1 SYNE2

5.83e-053154217462627
Pubmed

Dual functions of Rap1 are crucial for T-cell homeostasis and prevention of spontaneous colitis.

RAP1A RAP1B

5.83e-053154226634692
Pubmed

Structures of FHOD1-Nesprin1/2 complexes reveal alternate binding modes for the FH3 domain of formins.

SYNE1 SYNE2

5.83e-053154233472039
Pubmed

Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells.

SYNE1 SYNE2

5.83e-053154225516977
Pubmed

Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.

RAP1A RAP1B MYL3 OBSCN DES WASHC5 AFDN CTSD

6.73e-05304154832235678
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

USP34 GRIPAP1 DCPS KIF1B CAST CERT1 NSUN2 GMPS THOP1 WASHC5 PHACTR4 SEC23IP HARS1 HERC1 FTO KIF13A KYNU SNX1

8.36e-0514551541822863883
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

SYNE1 GMPS DST FAM186A HERC1 KIF13A SLC4A5

8.76e-05234154736243803
Pubmed

Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis.

CEBPA KMT2C ASCC2

9.18e-0520154319047629
InteractionNPAS1 interactions

GRIPAP1 SNX4 NHSL2 POLE TBC1D2B ANKLE2 WASHC5 SEC23IP RLIM IFT122 TNS4 HERC1

2.70e-0724514812int:NPAS1
InteractionRAB11A interactions

GRIPAP1 SNX4 RAP1B REXO4 TBC1D2B ANKLE2 YES1 NSUN2 DST ATP11B USO1 SYNE2 PHACTR4 SEC23IP LZTS2 KIF13A FMNL1 SNX1 MPP7

1.11e-0583014819int:RAB11A
CytobandEnsembl 112 genes in cytogenetic band chrXq22

TCP11X1 DRP2 TCP11X2 NRK PCDH19 TAF7L

2.59e-051721536chrXq22
Cytoband15q25.2

ADAMTSL3 GOLGA6L4 GOLGA6L10

4.06e-0443153315q25.2
GeneFamilySpectrin repeat containing nuclear envelope family

SYNE1 SYNE2

1.84e-04410121252
GeneFamilyPhosphatase and actin regulators

PHACTR2 PHACTR4

1.84e-0441012679
GeneFamilyMOB kinase activators|STRIPAK complex

MOB1B MOB1A

6.37e-0471012647
GeneFamilyRing finger proteins|Polycomb group ring fingers

PCGF1 PCGF5

6.37e-047101261
GeneFamilyRAS type GTPase family

RAP1A RAP1B RAP2C

6.79e-04311013389
GeneFamilyEF-hand domain containing|Plakins

PPL DST

8.46e-0481012939
GeneFamilySorting nexins|PX-BAR domain containing

SNX4 SNX1

1.97e-031210121290
CoexpressionGSE14769_40MIN_VS_360MIN_LPS_BMDM_DN

RAP1B KDM5D ANKLE2 NXPE3 KMT2C OAF ZC3H4 TNS4 HERC1 SPEN

2.36e-0719915010M3517
CoexpressionGSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN

SATB2 SNX4 RGS9 KDM5D CERT1 CHRD C3 ATP2A2 CDH6

2.31e-061991509M4142
CoexpressionGENTILE_UV_RESPONSE_CLUSTER_D2

SATB2 SNX4 CHD1 ZC3H4 PHF3

2.47e-06381505M12861
CoexpressionPUJANA_ATM_PCC_NETWORK

USP34 RAP1A SNX4 RAP1B PCGF1 POLE CAST OBSCN RNF114 BBS9 ATP11B TCERG1 WASHC5 ZC3H4 PHF3 SGPL1 RALBP1 SEC23IP MOB1A SMARCD2 KYNU FMNL1 ECE2

4.55e-06139415023M9585
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

CEP104 SMG1 TUT4 POLE KMT2C PHACTR4 HERC1 ATP2A2

9.71e-061801508M8239
CoexpressionDAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP

CEP104 SATB2 DIPK1A KIF1B DST SGPL1 SYNE2 DLK2 DIXDC1 FTO

2.78e-0534015010M2012
CoexpressionGSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN

CEP104 COL12A1 SQLE SH3RF2 DIXDC1 ATP2A2 EPHA7

5.15e-051671507M6699
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF1B INSRR KDM5D KMT2C DST CLK1 HERC1 ATP2A2

4.10e-0719515483e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF1B INSRR KDM5D KMT2C DST CLK1 HERC1 ATP2A2

4.10e-0719515487796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

USP34 SMG1 CAST CHD1 KMT2C CLK1 PHF3 SYNE2

4.96e-07200154812f1685ce8f218433068e090c9d839cd5a1910bf
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL3 RAX POSTN DES NT5DC2 PCDH19 CDH6

3.40e-0618215479edaccf1154cec92ca9a28e9b1f9075cfd422bfd
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL3 RAX POSTN DES NT5DC2 PCDH19 CDH6

3.40e-061821547aba4c06d5d7618ac21b2695bca8e7a1346a91090
ToppCellnormal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

RAP1B SYNE1 KDM5D YES1 SYNE2 MYO1F CTSD

3.78e-061851547b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 SYNE1 DNAH14 NRK SYNE2 CDH6 EPHA7

3.92e-061861547f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

USP34 SMG1 CHD1 KMT2C SYNE2 HERC1 SPEN

4.21e-061881547ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 SYNE1 DNAH14 PPL CELSR1 NEK11 EPHA7

4.21e-06188154763a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCellIPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class

CFAP73 SYNE1 ARMC2 BBS9 DIXDC1 NEK11 CFAP46

5.00e-061931547ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CAPN12 RAP1B SYNE1 RGS9 YES1 SYNE2 MYO1F

5.35e-061951547609732e83ab7fc3ba7dace66f5a17e46557fd6d1
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CAPN12 RAP1B SYNE1 RGS9 YES1 SYNE2 MYO1F

5.35e-061951547acc603dc94ac6518adb0dffb43305b380ec75b52
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

USP34 SMG1 SYNE1 KMT2C SLC9A4 SYNE2 HERC1

5.72e-06197154757ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

USP34 SMG1 SYNE1 CLK1 PHF3 SYNE2 HERC1

6.11e-061991547f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

USP34 TUT4 COL12A1 KMT2C DST SYNE2 AFDN

6.31e-062001547dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ERBB3 PPL CELSR1 DST SYNE2 AFDN ATP2A2

6.31e-06200154797f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

SYNE1 POSTN DES DST DIXDC1 CDH6 EPHA7

6.31e-062001547dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ERBB3 PPL CELSR1 DST SYNE2 AFDN ATP2A2

6.31e-062001547ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCellfacs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEBPA ARHGAP30 WASHC5 MYO1F TNS4 ARHGEF37

1.74e-0515615463f0b9e35d4da85c90759b930052e5b9c3cde9b15
ToppCellfacs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEBPA ARHGAP30 WASHC5 MYO1F TNS4 ARHGEF37

1.74e-05156154669e6e8810d1738a66c9821910f41498931cf30cc
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYL3 OBSCN POSTN DES CHRD MTUS2

2.82e-051701546cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYL3 OBSCN POSTN DES CHRD MTUS2

2.82e-051701546da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

SMG1 TUT4 SYNE1 CHD1 SYNE2 HERC1

2.91e-0517115462e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellmild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CAPN12 ERBB3 SYNE1 YES1 SLC8A3 SYNE2

2.91e-0517115465c8198182495bda7a826e9d80aa467f4eb1094ec
ToppCellCOVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type

NHSL2 SYNE1 FRMD4A C3 CDH6 EPHA7

3.01e-05172154636a96714a0eb6ac438648135336c9791881ddadb
ToppCellPND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NHSL2 SYNE1 ATP11B MYO1F HERC1 CTSD

3.01e-051721546c05af6e559f6af0fb15cefa03ffa1413e98a1a4a
ToppCellPND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NHSL2 SYNE1 ATP11B MYO1F HERC1 CTSD

3.01e-051721546953b05f776348cff784e79c93df65841939d880f
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL3 POSTN DES NT5DC2 PCDH19 CDH6

3.31e-0517515462a53d4f140d5ab096efe8118d8aa351db7838b49
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL3 POSTN DES NT5DC2 PCDH19 CDH6

3.31e-051751546fb91a45763e4c48d993094a13088ffc19f1e2574
ToppCell5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CAPN12 ERBB3 CEBPA TRIM10 CELSR1 HSD3B1

3.42e-05176154624eedbbb406d788630bb16678cceef4492d3999c
ToppCellfacs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYL3 OBSCN DES ATP2A2 MTUS2 CFAP46

3.53e-051771546692cd03bf0958ebeec34d41bfe87713a768e9a8e
ToppCellfacs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYL3 OBSCN DES ATP2A2 MTUS2 CFAP46

3.53e-051771546c08583ea68bbeb6b5de852a46b0c0f04792dae55
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

INSRR F8 DST RLIM HERC1 ATP2A2

3.65e-051781546fcbbcc44271515de1969b4732b6441c012693d5f
ToppCellCOVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

COL12A1 NHSL2 SYNE1 FRMD4A DST C3

3.76e-051791546e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL3 RAX POSTN DES NT5DC2 PCDH19

3.76e-051791546f5bb4d3a27d56698473219970e764084096cc582
ToppCellfacs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL3 POSTN DES NT5DC2 PCDH19 CDH6

3.76e-0517915467078022e60faa86444f2a2c6eb9f767cc66b5cfa
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL3 RAX POSTN DES NT5DC2 PCDH19

3.76e-051791546fa03ec3cc0132f977b4cb28e7b23789732375183
ToppCellfacs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ADAMTSL3 POSTN DES NT5DC2 PCDH19 CDH6

3.76e-051791546d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07
ToppCelldroplet-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SQLE PPL ATP11B RALBP1 ENTPD5 AFDN

4.25e-0518315469e6c96ada930e8559246a270dfc69fb3cbb3bdf3
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL3 POSTN DES NT5DC2 PCDH19 CDH6

4.39e-0518415464cb5f299dd7413e0be1ad7af817ee614b23a18ae
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTSL3 POSTN DES NT5DC2 PCDH19 CDH6

4.39e-05184154639bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd
ToppCellnormal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

SYNE1 KDM5D YES1 FAM186A SYNE2 MYO1F

4.52e-051851546097d628f92e13250c15b550f2fd1f4225fc07558
ToppCellControl-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class

NTS POSTN DST OAF DLK2 TNS4

4.52e-051851546d5d6d13e2f20b54ca55645b9a757b8599f4fd897
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SNX4 RGS9 YES1 PHACTR4 PPP1R9B KIF13A

4.94e-0518815466468fa95ad0395395301115286f2d8c0df5d3882
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SNX4 RGS9 YES1 PHACTR4 PPP1R9B KIF13A

4.94e-0518815467a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SNX4 RGS9 YES1 PHACTR4 PPP1R9B KIF13A

4.94e-0518815469cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCelldroplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SATB2 SPTB RGS9 PPL CDH6 EPHA7

4.94e-051881546c300accbac71a3bc075fe985543d8a8ead82531b
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

COL12A1 ANKLE2 PPL SH3RF2 NRK AFDN

4.94e-05188154643a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 DNAH14 PPL CELSR1 SYNE2 EPHA7

5.09e-051891546904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CAPN12 RAP1B SYNE1 RGS9 YES1 SYNE2

5.24e-0519015461f890be1ac8613a098b271945f25a58c3c2530ab
ToppCellCOVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYL3 SPTB OBSCN ADAMTSL3 DES MTUS2

5.24e-051901546918ad5037881212008f9f69d5df5da91fd01422c
ToppCellSmart-seq2-blood_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CAPN12 RAP1B SYNE1 RGS9 YES1 SYNE2

5.24e-051901546d7cecf88451f736f8f3f6f4644504cf22846cd6e
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue

RAP1B TRAV6 SYNE1 RGS9 SYNE2 MYO1F

5.24e-05190154666d29f53f129fc18771f6214316a913eeaccd55e
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

RAP1B SYNE1 RGS9 KDM5D SYNE2 MYO1F

5.40e-051911546b2d0ea24970da09209da9d9dda76e30fbfe22917
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 DNAH14 PPL SYNE2 NEK11 EPHA7

5.40e-051911546d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCellfacs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CABP5 NTS YES1 F8 CELSR1 MPP7

5.40e-05191154648823a97c38263f2c6e58348214f5b62773a6368
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

TUT4 CHD1 PIK3CA CLK1 PHF3 HERC1

5.40e-0519115461ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCellfacs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CABP5 NTS YES1 F8 CELSR1 MPP7

5.40e-0519115460eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

ERBB3 TUT4 TCERG1 PHF3 AFDN GREB1

5.55e-051921546916fbec1c7ab7969bda711886ac88e877e30c280
ToppCelldroplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPTB OBSCN PM20D2 DES ATP2A2 MTUS2

5.55e-0519215460bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

SMG1 CHD1 KMT2C CLK1 SYNE2 HERC1

5.55e-05192154647646d7e4990be85072987f92bf18d52f8da752e
ToppCelldroplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

POSTN DES SLC8A3 SH3RF2 PCDH19 GREB1

5.55e-0519215462cc712186e37fb21a964c032765c36a8b4a852cf
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

RAP1B SYNE1 RGS9 KDM5D SYNE2 MYO1F

5.55e-051921546fdc741e1846cfd8ed741b160e3c611c310c5d36d
ToppCelldroplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPTB OBSCN PM20D2 DES ATP2A2 MTUS2

5.55e-051921546d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCell5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ERBB3 DCPS NTS POSTN FRMD4A CDH6

5.72e-0519315464f4f430d7e1b65e19ca829f55ca93edeb6c1c85d
ToppCellsevere-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SMG1 SYNE1 ZKSCAN8 SLC9A4 SYNE2 HERC1

5.72e-0519315469337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCellwk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

SPTB KDM5D TRIM10 FRMD4A ARHGEF37 HERC1

5.72e-051931546be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SATB2 SYNE1 PPL SYNE2 AFDN NEK11

5.88e-051941546e577d9e88390b36b5a09b97fe1026089892275a3
ToppCellnucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

COL12A1 OBSCN ADAMTSL3 POSTN DES CDH6

5.88e-0519415462d66091097e106c7bee22e5281f50724700bdf8d
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DNAH14 CELSR1 SYNE2 PHACTR4 AFDN CDH6

5.88e-0519415467002937e8903e037332a215d00fbc7c7843b33f2
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CAPN12 RAP1B SYNE1 RGS9 SYNE2 MYO1F

6.05e-05195154672f42f0be53a2a61f61647118b4883e752d998a5
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CAPN12 RAP1B SYNE1 RGS9 SYNE2 MYO1F

6.05e-05195154649a4f58aac168fc1838bd5d2b202135cd794c28b
ToppCell5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ERBB3 NTS POSTN FRMD4A DST CDH6

6.05e-0519515469fea1ddb68da83ca43dd8006c9e51295b1817f0e
ToppCellnormal-na-Lymphocytic_NK|normal / PBMC cell types (v2) per disease, treatment status, and sex

CAPN12 RAP1B SYNE1 YES1 SYNE2 MYO1F

6.05e-051951546cebe79c42af5910353ba9ad7d0edb01982f772a3
ToppCell5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ERBB3 NTS POSTN FRMD4A DST CDH6

6.23e-0519615469afd0a7135028a446f06bb68f334e79b8f171b45
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPTB OBSCN PM20D2 DES ATP2A2 MTUS2

6.23e-051961546a582130862bee76c0385156a333bfdfc75cf218b
ToppCelldroplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPTB OBSCN PM20D2 DES ATP2A2 MTUS2

6.23e-051961546fba52a4b82086dbae9a55038bf44c4539be926f5
ToppCell10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue

SYNE1 RGS9 YES1 SYNE2 MYO1F CTSD

6.23e-051961546f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

RAP1B SYNE1 RGS9 YES1 SYNE2 MYO1F

6.23e-051961546c25f90c4e5abfe7cfaa85bfe136c438a5179c978
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

RAP1B SYNE1 RGS9 YES1 SYNE2 MYO1F

6.23e-051961546d451f279f4086fcf727af712f98923551181c76e
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHACTR2 PPL POSTN CELSR1 OAF EPHA7

6.23e-051961546dbf154b3d166ffd07be717dac8d8a3350ac63e16
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SYNE1 RGS9 YES1 SYNE2 MYO1F CTSD

6.40e-051971546f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP73 SYNE1 ARMC2 SYNE2 NEK11 CFAP46

6.40e-05197154674a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

RAP1B SYNE1 RGS9 YES1 SYNE2 MYO1F

6.40e-051971546550cce374332c49893bcf4ce4b7dceb7f5fe26aa
ToppCellCOVID-19_Mild|World / Disease group, lineage and cell class

SMG1 TUT4 CHD1 KMT2C PHF3 FMNL1

6.40e-0519715465c33454b10023decd2f5ccda9229b6512659711e
ToppCellnormal-na-Lymphocytic_NK-natural_killer_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex

CAPN12 RAP1B SYNE1 YES1 SYNE2 MYO1F

6.40e-05197154673a33d8b27043ba3074d04bc2d18cd287e00117f
ToppCellsystemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

RAP1B TUT4 SYNE1 ARHGAP30 PHF3 SYNE2

6.59e-0519815464c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCellSepsis-URO-Lymphocyte-T/NK-CD4+_CTL|URO / Disease, condition lineage and cell class

DIPK1A SYNE1 SPTB RGS9 GOLGA6L10 SYNE2

6.59e-051981546c53405a8d082fbd10131a6ec88b69fdd835f2925
ToppCellEpithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id

POSTN DST OAF DLK2 TNS4 CDH6

6.59e-0519815464235005c49fc2b29ad3a0ee6b608f0109d04f775
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)

SMG1 TUT4 CHD1 KMT2C PHF3 FMNL1

6.59e-05198154644417089b62056269cac38d3134ff209c05b7007
ToppCell(0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)

RAP1B SYNE1 CAST RGS9 SYNE2 MYO1F

6.59e-051981546eba39656c6f699ab297b652ded8cb9727b49593c
ToppCellParenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

ARMC2 NXPE3 DES DST SMARCD2 CDH6

6.59e-051981546cc2b5b632e73e44bb60050f0db10d8f0dbb859fa
ToppCellBronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X

NTS POSTN DST SYNE2 DLK2 TNS4

6.59e-051981546f5b7013045b61fc56894f80092f799770dde1c8f
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SMG1 TUT4 CHD1 KMT2C PHF3 FMNL1

6.59e-05198154628ef3fc4c17dcb765537b75917f7db78baa522db
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

RAP1B SYNE1 RGS9 YES1 SYNE2 MYO1F

6.59e-0519815465607e36f393cb399fcc2504502498453fd32d96b
ToppCellT/NK_cells-CD8+_Naive_T_cell|T/NK_cells / Lineage and Cell class

RAP1B CAST SYNE2 MYO1F CTSD FMNL1

6.59e-0519815465b78118af2283f2e1ad9c6a6ab448a018bf2f2e0
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

SYNE1 POSTN DES DST DIXDC1 EPHA7

6.77e-051991546e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCellwk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

COL12A1 ADAMTSL3 CERT1 OAF NRK C3

6.77e-0519915468de6d7b2067b22cb9b5f01aa56a3803aebc4406d
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

PHACTR2 DST PHF3 RALBP1 SYNE2 RLIM

6.77e-051991546c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellParenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

COL12A1 SPTB DES NT5DC2 CHRD CDH6

6.77e-0519915467c272a1aa7f3e931ad5d20809719d85b3bce4cb0
DiseaseFEV/FEC ratio

USP34 ERBB3 DIPK1A SOX30 KIF1B CDH23 ADAMTSL3 ARMC2 SH3D21 DES FRMD4A DST SYNE2 MYO1F ASCC2 HERC1 FTO KIF13A MPP7

1.46e-05122814919EFO_0004713
DiseaseVascular anomaly

YES1 PIK3CA

2.53e-0521492C0158570
Diseaseage at menarche

CYLC2 USP34 EEF1AKMT4-ECE2 SATB2 CAST DST ZC3H4 NT5DC2 SEC23IP GREB1 FTO ECE2

5.16e-0559414912EFO_0004703
DiseaseMalignant Head and Neck Neoplasm

ERBB3 CEBPA FANCF PIK3CA

7.24e-05441494C0278996
DiseaseProstatic Neoplasms

ERBB3 CHD1 PPL KMT2C USO1 PIK3CA RALBP1 RLIM HSD3B1 GREB1 CTSD SPEN

7.29e-0561614912C0033578
DiseaseMalignant neoplasm of prostate

ERBB3 CHD1 PPL KMT2C USO1 PIK3CA RALBP1 RLIM HSD3B1 GREB1 CTSD SPEN

7.29e-0561614912C0376358
DiseaseBenign neoplasm of stomach

ERBB3 POLE PIK3CA

8.15e-05171493C0153943
DiseaseNeoplasm of uncertain or unknown behavior of stomach

ERBB3 POLE PIK3CA

8.15e-05171493C0496905
DiseaseCarcinoma in situ of stomach

ERBB3 POLE PIK3CA

8.15e-05171493C0154060
DiseaseAdenocarcinoma of large intestine

POLE PIK3CA NRK NEK11 EPHA7

1.30e-04961495C1319315
DiseaseKabuki make-up syndrome

RAP1A RAP1B

1.51e-0441492C0796004
DiseaseAutosomal dominant Emery-Dreifuss muscular dystrophy

SYNE1 SYNE2

1.51e-0441492cv:CN293514
DiseaseStomach Carcinoma

ERBB3 POLE PIK3CA

1.57e-04211493C0699791
DiseaseNasopharyngeal carcinoma

ERBB3 SYNE1 PIK3CA

1.81e-04221493C2931822
DiseaseColorectal Carcinoma

SATB2 SYNE1 POLE OBSCN CHD1 ADAMTSL3 POSTN KMT2C PIK3CA TNS4 LZTS2 EPHA7

2.45e-0470214912C0009402
DiseaseAutosomal Recessive Emery-Dreifuss Muscular Dystrophy

SYNE1 SYNE2

2.51e-0451492C1450051
DiseaseAutosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)

SYNE1 SYNE2

2.51e-0451492C0410190
Diseasenon-lobar intracerebral hemorrhage

CYP20A1 DNAH14 FRMD4A FTO

2.95e-04631494EFO_0010178
DiseaseEmery-Dreifuss muscular dystrophy

SYNE1 SYNE2

3.75e-0461492cv:C0410189
DiseaseMuscular Dystrophy, Emery-Dreifuss

SYNE1 SYNE2

3.75e-0461492C0410189
DiseaseUsher syndrome

CDH23 HARS1

5.23e-0471492cv:C0271097
DiseaseCUB domain-containing protein 1 measurement

DCPS SARM1

5.23e-0471492EFO_0802432
DiseaseX-Linked Emery-Dreifuss Muscular Dystrophy

SYNE1 SYNE2

5.23e-0471492C0751337
DiseaseHead and Neck Neoplasms

ERBB3 CEBPA PIK3CA

6.16e-04331493C0018671
Diseasezinc-alpha-2-glycoprotein measurement

SARM1 NPHS2

6.95e-0481492EFO_0802228
Diseasecalcium/calmodulin-dependent protein kinase type 1D measurement

SARM1 C3

6.95e-0481492EFO_0008063
Diseasemean reticulocyte volume

CEBPA DIPK1A SPTB CHD1 ARMC2 TRIM10 PIK3CA SGPL1 MOB1B SEC23IP AFDN CDH6

7.72e-0479914912EFO_0010701
Diseasechronic obstructive pulmonary disease

ERBB3 KIF1B FREM3 ADAMTSL3 ARMC2 DES FRMD4A ASCC2 FTO KIF13A ATP2A2

7.73e-0468814911EFO_0000341
Diseaseapolipoprotein A-V measurement

SARM1 APOA4

8.91e-0491492EFO_0801387
Diseasecellular retinoic acid-binding protein 1 measurement

SARM1 C3

8.91e-0491492EFO_0801463
Diseasemembranous glomerulonephritis (implicated_via_orthology)

NPHS2 C3

8.91e-0491492DOID:10976 (implicated_via_orthology)
Diseasetumor necrosis factor ligand superfamily member 14 measurement

SARM1 C3

8.91e-0491492EFO_0010613
Diseasereticulocyte measurement

USP34 CEBPA DIPK1A SPTB RGS9 SH3D21 TRIM10 ATP11B PIK3CA ZC3H4 SGPL1 SYNE2 ASCC2 AFDN

9.32e-04105314914EFO_0010700
Diseaseabdominal aortic aneurysm (is_marker_for)

POSTN FTO

1.11e-03101492DOID:7693 (is_marker_for)
DiseaseOCIA domain-containing protein 1 measurement

SARM1 C3

1.11e-03101492EFO_0008252
DiseaseHead and Neck Carcinoma

ERBB3 PIK3CA

1.11e-03101492C3887461
DiseaseUterine leiomyoma

SYNE1 ARMC2 GREB1 RAP2C

1.19e-03911494HP_0000131
DiseaseCharcot-Marie-Tooth disease

DRP2 KIF1B SGPL1

1.25e-03421493cv:C0007959
Diseaseobsolete_red blood cell distribution width

DIPK1A SPTB CDH23 FREM3 BBS9 F8 TRIM10 FRMD4A ATP11B ZC3H4 SGPL1 MOB1B SYNE2 AFDN HERC1 FTO

1.32e-03134714916EFO_0005192
Diseasenasopharynx carcinoma (is_marker_for)

ERBB3 KMT2C SPEN

1.34e-03431493DOID:9261 (is_marker_for)
Diseaseschizophrenia, gastroesophageal reflux disease

SATB2 ATP2A2

1.35e-03111492EFO_0003948, MONDO_0005090
DiseaseEmery-Dreifuss muscular dystrophy (implicated_via_orthology)

SYNE1 SYNE2

1.62e-03121492DOID:11726 (implicated_via_orthology)
Diseaseamyotrophic lateral sclerosis (biomarker_via_orthology)

KIF1B C3

1.90e-03131492DOID:332 (biomarker_via_orthology)
DiseaseAlzheimer's disease (is_marker_for)

PHACTR2 CEBPA CAST SLC8A3 PPP1R9B CTSD

2.00e-032571496DOID:10652 (is_marker_for)
DiseaseNephrosis

DES NPHS2

2.55e-03151492C0027720
DiseaseSynostotic Posterior Plagiocephaly

BBS9 IFT122

2.90e-03161492C1833340
DiseaseCraniosynostosis, Type 1

BBS9 IFT122

2.90e-03161492C4551902
DiseaseAcrocephaly

BBS9 IFT122

2.90e-03161492C0030044
DiseaseTrigonocephaly

BBS9 IFT122

2.90e-03161492C0265535
DiseaseScaphycephaly

BBS9 IFT122

2.90e-03161492C0265534
DiseaseSynostotic Anterior Plagiocephaly

BBS9 IFT122

2.90e-03161492C2931150
DiseaseMetopic synostosis

BBS9 IFT122

2.90e-03161492C1860819
DiseaseColorectal Neoplasms

SATB2 SYNE1 POLE CHD1 POSTN PIK3CA

2.91e-032771496C0009404
Diseaseadult onset asthma

ERBB3 CEBPA ADAMTSL3 SLC9A4

3.07e-031181494EFO_1002011
DiseaseBrachycephaly

BBS9 IFT122

3.28e-03171492C0221356
DiseaseMalignant neoplasm of skin

ERBB3 CEBPA POLE

3.34e-03591493C0007114
DiseaseSkin Neoplasms

ERBB3 CEBPA POLE

3.34e-03591493C0037286
Diseasesmoking behavior, BMI-adjusted waist circumference

KIF1B ADAMTSL3 NT5DC2 MYO1F

3.46e-031221494EFO_0004318, EFO_0007789
Diseasedisease progression measurement

CDH23 CELSR1 HERC1

3.67e-03611493EFO_0008336
Diseaseessential hypertension (is_implicated_in)

FTO ATP2A2

3.67e-03181492DOID:10825 (is_implicated_in)
Diseasemean arterial pressure

GRIPAP1 MYL3 YES1 PPL FANCF OAF FTO ATP2A2

3.96e-034991498EFO_0006340
DiseaseSarcomatoid Renal Cell Carcinoma

PIK3CA SYNE2 HARS1 CTSD

4.10e-031281494C1266043
DiseaseChromophobe Renal Cell Carcinoma

PIK3CA SYNE2 HARS1 CTSD

4.10e-031281494C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

PIK3CA SYNE2 HARS1 CTSD

4.10e-031281494C1266044
DiseasePapillary Renal Cell Carcinoma

PIK3CA SYNE2 HARS1 CTSD

4.10e-031281494C1306837
DiseaseRenal Cell Carcinoma

PIK3CA SYNE2 HARS1 CTSD

4.10e-031281494C0007134
DiseaseDisorder of eye

CDH23 RGS9 BBS9 HARS1 CTSD

4.53e-032121495C0015397
Diseasechronic kidney disease (is_marker_for)

APOA4 POSTN

4.53e-03201492DOID:784 (is_marker_for)
DiseaseCraniosynostosis

BBS9 IFT122

4.53e-03201492C0010278
Diseasebrain age measurement

EEF1AKMT4-ECE2 ECE2

4.53e-03201492EFO_0010602
Diseasememory performance

CAPN12 KIF1B ARMC2 BBS9 NT5DC2 SYNE2 CFAP46

4.88e-034091497EFO_0004874
DiseaseST2 protein measurement

DCPS SLC9A4

4.99e-03211492EFO_0010599
DiseaseInfiltrating duct carcinoma of female breast

SMG1 NRK

4.99e-03211492C3165106

Protein segments in the cluster

PeptideGeneStartEntry
ERRLDIDEKPLVVQL

AFDN

101

P55196
RLAEVPDLLEKGERL

ERBB3

916

P21860
RLKLLNPDDLREEIV

ANKLE2

71

Q86XL3
EIRVLDKAFGPELRE

HSD3B1

31

P14060
RKEPELQRHIQGIVE

ARHGEF37

136

A1IGU5
TRIVPILRELEKEEN

ARMC2

271

Q8NEN0
QVLRTKVPREGQEED

ASCC2

646

Q9H1I8
KPVQDLRQDLRDGVI

DIXDC1

41

Q155Q3
EGLQVEEKERPVQRL

CFAP46

2251

Q8IYW2
TLDPERLGREGVQKE

C3

946

P01024
IIDEEQLRGDRRQPL

CYLC2

61

Q14093
DISRRENGEVLPLKI

CELSR1

2456

Q9NYQ6
PVLRLLEKRQELVDA

CFAP73

31

A6NFT4
PQLGKRKRELDVEEA

DCPS

6

Q96C86
PVEGVLRVRKDVELD

CDH23

1796

Q9H251
LDRPEKGLSEREQLE

CHD1

1431

O14646
RDERTLINPDIKVVD

CLK1

311

P49759
DSKPLDVIEEERRLG

MTUS2

446

Q5JR59
LPETQAGIKEEIRRQ

RALBP1

391

Q15311
LREQILRVKDTEDVP

RAP1A

96

P62834
LREQILRVKDTDDVP

RAP1B

96

P61224
LILVGNKVDLEPERE

RAP2C

111

Q9Y3L5
DEDVKEAIRRLPENL

UQCRB

41

P14927
PVILRQLEEEAKARE

RGS9

446

O75916
IPRLQIDVDGRKEIL

NSUN2

246

Q08J23
EIGKELEELRARLLP

APOA4

101

P06727
RREVEENGIVLDPLK

CERT1

431

Q9Y5P4
ISKNDIRLVPRDVEE

PCDH19

781

Q8TAB3
EEIIFKLVPGLREQE

PCGF5

76

Q86SE9
KLVPGLREQELERES

PCGF5

81

Q86SE9
EVLRVVRGKLHQPEE

ENTPD5

306

O75356
LERLQEVGKAEAERP

FANCF

171

Q9NPI8
PEEQLVIERLQGEKE

KMT2C

711

Q8NEZ4
IDLEVLRPKRDDRQL

IFT122

1111

Q9HBG6
EREQRELGPRLEETK

LZTS2

426

Q9BRK4
ELERNRQEELGIKPQ

GREB1

1621

Q4ZG55
EVLRVLGKPRQEELN

MYL3

91

P08590
KIGVIRLLDPEDVDV

DST

221

Q03001
VKREGLPVEQRNEIL

FTO

421

Q9C0B1
VGRIRNKPEVDEAAV

KIF1B

1316

O60333
VSPVIDELQKRREEG

HERC1

1456

Q15751
RDLPVGLEELRQLEL

KDM5D

1046

Q9BY66
IAEKQRERPLGQDEI

CABP5

16

Q9NP86
ERIEELGAQPLRDLI

ECE2

231

P0DPD6
RPLSDIEGARELQEK

KIAA1586

261

Q9HCI6
LEALRRRGPQVEVKE

PPL

1216

O60437
REVNGIPVEDKRPEE

MPP7

186

Q5T2T1
EIALERPEKEIRNEG

NEK11

496

Q8NG66
ERIEIKDVRLPAGLQ

NPHS2

261

Q9NP85
EKLPGQERLLEEVEK

GOLGA6L3

331

A6NEY3
QEKLPGQERLLEEVE

GOLGA6L4

316

A6NEF3
LPGQERLLEEVEKLL

GOLGA6L10

326

A6NI86
QEKLPGQERLLEEVE

GOLGA6L19

351

H0YKK7
QFRLPLEETELEKRI

F8

1336

P00451
ALEIDPTVQRVKRDE

KRT82

106

Q9NSB4
LEEVQLLKPRVVIDG

NLRP5

1171

P59047
IDRRELAPLQELIEK

MOB1B

196

Q7L9L4
ARELIEQIGRPLELD

POLE

846

Q07864
IRRGVLKELPDQDGD

PHACTR2

76

O75167
ERAERPKFEQIVGIL

EPHA7

876

Q15375
EELVKRGVLLEDPEQ

PHACTR4

76

Q8IZ21
VIEPVGNREEKILNR

PIK3CA

101

P42336
EVDLRDPVLQVEVGK

BBS9

71

Q3SYG4
LDEPAELGLRERVKA

OBSCN

7406

Q5VST9
GEVHEEELVARRKLP

NTS

76

P30990
QKILPKGEEAELERL

FRMD4A

451

Q9P2Q2
QVERIEELGAQPLRD

EEF1AKMT4-ECE2

301

P0DPD8
EELGAQPLRDLIEKI

EEF1AKMT4-ECE2

306

P0DPD8
VEIAVGDKVPADIRL

ATP2A2

151

P16615
DVVVDDRLPVREGKL

CAPN12

151

Q6ZSI9
IIQEVEENPDLRKGE

CENPB

16

P07199
QDPEVAQIIRKLDER

CEP104

206

O60308
ELLEREARGEVKVTP

IDI2

181

Q9BXS1
ELIRKLREEGKVIEP

GMPS

396

P49915
KDEVRILGRELGLPE

GMPS

416

P49915
PKLQARERGEEQVEL

C2CD2L

221

O14523
GKSQDEVEIPARELR

COL12A1

251

Q99715
RPLVIKQEPREEDEA

CEBPA

156

P49715
DEVRELQKAIGAVPL

CTSD

306

P07339
RKLLEGEESRINLPI

DES

406

P17661
VIERDLKEPDRIVGE

SQLE

151

Q14534
PKDDDVIRNIIRLRE

DNAH14

251

Q0VDD8
RQAEPELDLRSIKEV

CAST

301

P20810
EIQEDKVPRERAVLS

INSRR

761

P14616
EELEEKGLIRILRGP

FMNL1

481

O95466
EAIEDNKLRRDIVPE

CDH6

681

P55285
LQDIEGKIDRFIIPR

CYP20A1

346

Q6UW02
VKEVVRRQEAGLGEP

DLK2

291

Q6UY11
PERGLEDLERQIKTK

FAM186A

971

A6NE01
VLRDLVKPGDENLRE

GRIPAP1

776

Q4V328
RGAPSEIREELEKQL

DIPK1A

376

Q5T7M9
REELAKEIGVPESRV

DUXA

131

A6NLW8
REDLVEEIKRRTGQP

HARS1

491

P12081
ERLEEERGILVNVPL

DRP2

456

Q13474
LVPGLQDSEEKRIRE

PCGF1

111

Q9BSM1
EAVGVQLEPERLVKI

ARHGAP30

116

Q7Z6I6
DPNAKVIRELREEVE

KIF13A

361

Q9H1H9
GIPLIFEREEAIKEQ

NRK

341

Q7Z2Y5
KIEEDIGELLIPVRR

FREM3

1896

P0C091
IRPENLKQGEELEVV

REXO4

296

Q9GZR2
IESPDVENEVKRLLR

TAF7L

256

Q5H9L4
GIQPEEIGRLREEIE

USO1

726

O60763
SLPREGQEKVLDRLD

RMDN3

81

Q96TC7
ETPEQREARIKVLEE

SNX4

366

O95219
PDELALRRGDVVKVL

SH3D21

81

A4FU49
PVRDEAIQKLETIRD

TCP11X1

171

B4DZS4
PVRDEAIQKLETIRD

TCP11X2

76

Q5H9J9
LENIDRRKNEIVPID

SYNE1

8566

Q8NF91
LKQEQEGVERDRLPA

SYNE2

4071

Q8WXH0
VEDEGPKVRVLPERI

NHSL2

971

Q5HYW2
SEGIRVLQRLQEDKP

NXPE3

191

Q969Y0
IDRRELAPLQELIEK

MOB1A

196

Q9H8S9
EGVRLLPREKSEVQN

SMG1

1641

Q96Q15
QGLLSEILRKEEDPR

SATB2

391

Q9UPW6
QRIQGIKRLSPEDVE

SLC9A4

576

Q6AI14
PRVVKRGIDDNLDEI

SEC23IP

421

Q9Y6Y8
ELRVRVRLPDGQVTE

OAF

31

Q86UD1
LDVIFKPELLEGIRE

PM20D2

406

Q8IYS1
AIREGVIKTEEPERL

SOX30

206

O94993
REELAGKVNLPEVRV

RAX

166

Q9Y2V3
DIFPGLRKIEAEIVR

SGPL1

176

O95470
RRDLKIITDVIGNPE

SMARCD2

476

Q92925
EAQGVVKDLEPELLR

CHRD

606

Q9H2X0
RVGDIVRIAKDEIFP

ATP11B

141

Q9Y2G3
LREQILRVKDTDDVP

nan

96

A6NIZ1
DPKQLLEDGIRKELV

WASHC5

701

Q12768
EVILLREGEAERKPV

SPEN

1026

Q96T58
VREFLEKEELPRAVG

SNX1

261

Q13596
LAPGVRAVELERQIE

RNF114

71

Q9Y508
GVILNLAKEREPVEL

SARM1

166

Q6SZW1
DLIGRADVDKIIQEP

TCERG1

561

O14776
REQAIELLRKEEPGA

TNS4

456

Q8IZW8
ELLRKEEPGAFVIRD

TNS4

461

Q8IZW8
LELVAEVRIGDRDPI

SCAF1

126

Q9H7N4
EEELLRRLQQIKEGP

RLIM

61

Q9NVW2
ELILPNRNLRDKVEE

PHF3

106

Q92576
IEKQIEDGLLRPELR

SLC4A5

191

Q9BY07
LKERQIAERPAEETG

SPTB

2076

P11277
GAIIPELEREIRIIN

NT5DC2

376

Q9H857
KEDVELRTGIPRQLL

RIOX2

281

Q8IUF8
EEGERALREKAVNIP

ZC3H4

926

Q9UPT8
EDVQRKGELRLRPEE

TRIM10

386

Q9UDY6
GVKVPRNFRLLEELE

UBE2V2

6

Q15819
QEGAREREELPKEIP

VSIG10

481

Q8N0Z9
PDELDLQKGEGVRVL

SH3RF2

396

Q8TEC5
IPIGNKKEEEELRRT

USP34

496

Q70CQ2
NEAFEKLPRGVLERI

POSTN

276

Q15063
EKETREERIITGPEI

POSTN

746

Q15063
DEEIKRLLQGDTPVR

POSTN

801

Q15063
VPRELLEKLIESRQA

THOP1

531

P52888
PEQRLGLKQAEERLE

TUT4

271

Q5TAX3
LEEVPLEVLRQRESK

TBC1D10A

71

Q9BXI6
EQLLGEEPEKRRRQE

TCHH

971

Q07283
VVPVARDQLELDRLK

TBC1D2B

476

Q9UPU7
RGPVFLLLIRENEKE

TRAV6

81

A0A075B6T7
LEDLERQIDILGRPV

ZKSCAN8

126

Q15776
EIPRESLRLEVKLGQ

YES1

271

P07947
EKREENVIAVPLGSR

ADAMTSL3

241

P82987
KPREGEETLRIEDIL

KYNU

191

Q16719
LEERPELRQFLGKRE

MYO1F

746

O00160
LVPLEGKEVDESRRE

SLC8A3

301

P57103
EKRVERLELFPVELE

PPP1R9B

486

Q96SB3